Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 12 Feb 2019, Professor Arjen Dondorp published a new book: Sepsis Management in Resource-limited Settings. The result of a 3-year project led by MORU and the European Society of Intensive Care Medicine (ESICM), the book was written by critical care physicians from around the globe.

Arjen Dondorp managing a patient in a hospital

Coordinated by honorary MORU member Marcus Schultz, Professor of Intensive Care Medicine in Amsterdam, with Martin Dünser, an intensivist from Austria, and Arjen Dondorp, Head of Malaria and Critical Illness (MORU), Sepsis Management in Resource-limited Settings critically evaluates the “surviving sepsis campaign” guidelines and adapts these for hospitals in resource-limited settings with constraints in human and material resources and examines the different causes of sepsis in the tropical world.

Sepsis guidelines from high-income settings are often not applicable to resource-limited settings because of differences in human and material resources and causes of sepsis. Systematic reviews of evidence generated in resource-poor settings, supplemented by the experiences from authors working in these settings provide a rich source of practical advice for the management of severe sepsis. A wide range of topics are covered in the 10 chapters of the book.

With support from the Wellcome Trust the book has been published in open access format by Springer. The authors hope it will be used widely.

In the foreword, Sir Jeremy Farrar, director of the Wellcome Trust, says: “This book, authored by people all looking after patients with sepsis today, is inspiring; a brilliant summary of what is known, how to best apply what is known wherever you work; and a pleasure to read whatever your personal experience or qualifications.”

Please join us in congratulating Arjen, Martin and Marcus for this important achievement!

Similar stories

Congratulations Professor Sir David Warrell, appointed Knight Commander of the Order of St Michael and St George

David Warrell, our founding director, has been appointed by the Queen ‘Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice’. Please join us in congratulating Sir David on receiving this richly deserved high honour!

Patient recruitment on track in Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa

Today is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.

TACT-CV study shows artemether–lumefantrine plus amodiaquine an effective treatment for multidrug-resistant malaria in GMS

A triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.

Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes

A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published in BMC Medicine by the WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group

Study finds steady increase in WHO-validated artemisinin resistance markers in Asia

From 2002-2018, there has been a steady increase in the places and proportion of infected people reporting validated kelch13 (K13) artemisinin resistance markers, according to a study in The Lancet Microbe. This increase in artemisinin resistance threatens efforts to eliminate malaria in Asia by 2030 — and control efforts in other endemic regions. The authors say that more consistent data collection, over longer time periods in the same areas, and rapid sharing of data are needed to map the spread of resistance and better inform policy decisions.

Global Research on AntiMicrobial resistance (GRAM) project

Antimicrobial resistance (AMR) is responsible for at least 1.27 million deaths per year — with over 97,000 deaths in 2019 in SE Asia alone, according to a study published in The Lancet by the Global Research on AntiMicrobial resistance (GRAM) project, who urged urgent action from policymakers and health communities to avoid further preventable deaths.